Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Hong

Showing results (291-300 of 379) with videos related to

Pageof 38
Sort By:
Arthritis Research & Therapy|December 13, 2019
The value of MRI examination on bilateral hands including proximal interphalangeal joints for disease assessment in patients with early rheumatoid arthritis: a cross-sectional cohort studyYing-Qian Mo, Ze-Hong Yang, Jun-Wei Wang, et al.
Ebiomedicine|March 26, 2025
Sodium glucose co-transporter 2 inhibitor prevents nephrolithiasis in non-diabetes by restoring impaired autophagic fluxChan-Jung Liu, Kaun-Ta Ho, Ho-Shiang Huang, et al.
European Journal of Medicinal Chemistry|July 5, 2022
Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactoneMuzaffar Kayumov, Li Jia, Azizbek Pardaev, et al.
Journal of Medicinal Chemistry|February 4, 2025
Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 InhibitorsJunjie Zhang, Benjin Liu, Ruyue Ren, et al.
European Journal of Medicinal Chemistry|June 18, 2024
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitorsHongrui Li, Ben-Jin Liu, Jiahao Xu, et al.
Biochemical Pharmacology|February 4, 2021
Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1Qian Wu, Dan-Qi Chen, Lin Sun, et al.
Molecular Cancer Therapeutics|April 2, 2014
MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189Wei Wang, Ying-Qing Wang, Tao Meng, et al.
Marine Drugs|January 19, 2019
Cytotoxic Nitrogenous Terpenoids from Two South China Sea Nudibranchs <i>Phyllidiella pustulosa</i>, <i>Phyllidia coelestis</i>, and Their Sponge-Prey <i>Acanthella cavernosa</i>Qihao Wu, Wen-Ting Chen, Song-Wei Li, et al.
Molecular Cancer|October 12, 2010
Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolideZhao-Li Zhou, Zhi-Guo Luo, Bing Yu, et al.
Plos Pathogens|March 9, 2017
The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune responseQiang Wang, Liyuan Huang, Ze Hong, et al.
Pageof 38

Showing results (291-300 of 379) with videos related to

Sort By:
Pageof 38
Arthritis Research & Therapy|December 13, 2019
The value of MRI examination on bilateral hands including proximal interphalangeal joints for disease assessment in patients with early rheumatoid arthritis: a cross-sectional cohort studyYing-Qian Mo, Ze-Hong Yang, Jun-Wei Wang, et al.
Ebiomedicine|March 26, 2025
Sodium glucose co-transporter 2 inhibitor prevents nephrolithiasis in non-diabetes by restoring impaired autophagic fluxChan-Jung Liu, Kaun-Ta Ho, Ho-Shiang Huang, et al.
European Journal of Medicinal Chemistry|July 5, 2022
Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactoneMuzaffar Kayumov, Li Jia, Azizbek Pardaev, et al.
Journal of Medicinal Chemistry|February 4, 2025
Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 InhibitorsJunjie Zhang, Benjin Liu, Ruyue Ren, et al.
European Journal of Medicinal Chemistry|June 18, 2024
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitorsHongrui Li, Ben-Jin Liu, Jiahao Xu, et al.
Biochemical Pharmacology|February 4, 2021
Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1Qian Wu, Dan-Qi Chen, Lin Sun, et al.
Molecular Cancer Therapeutics|April 2, 2014
MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189Wei Wang, Ying-Qing Wang, Tao Meng, et al.
Marine Drugs|January 19, 2019
Cytotoxic Nitrogenous Terpenoids from Two South China Sea Nudibranchs <i>Phyllidiella pustulosa</i>, <i>Phyllidia coelestis</i>, and Their Sponge-Prey <i>Acanthella cavernosa</i>Qihao Wu, Wen-Ting Chen, Song-Wei Li, et al.
Molecular Cancer|October 12, 2010
Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolideZhao-Li Zhou, Zhi-Guo Luo, Bing Yu, et al.
Plos Pathogens|March 9, 2017
The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune responseQiang Wang, Liyuan Huang, Ze Hong, et al.
Pageof 38